Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

HIV/AIDS could kill 20% of southern Africa’s farm workers by 2020
2008-09-27

HIV / AIDS is claimed to account for 40% - 50% of infections in the workforce in some labor-intensive industries. This means that every farmer will have to replace up to 50% of his workforce within the next 10 years.

This was said by Mrs Estelle Heideman (pictured) of the Faculty of Natural and Agricultural Science at the University of the Free State (UFS) at the launch of a DVD about a project to equip farm workers with knowledge and skills regarding HIV / AIDS.

Mrs Heideman was quoting the research findings of Agrimark Consultant, Johan Willemse, and added that farm workers, because of low literacy levels, remoteness of the areas in which they live and the distances to health care facilities, are often forgotten when it comes to HIV/AIDS prevention and care programmes.

This weekend Mrs Heideman leaves for New York City to take up a scholarship awarded to her by the University of Columbia and the University of California, Los Angeles (UCLA) to participate in the M-A-C AIDS Sponsored Leadership Programme.

The leadership Initiative provides a structured support program to enable participants to exchange best practices in the approach to HIV prevention that can be adapted to local circumstances. At the conclusion of the program the Leadership Initiative will, amongst other benefits, provide funds for Fellows to carry out their prevention program in South Africa.

Such a program was already carried out from February to May this year as part of the Lengau Agri Centre’s Farm Project in collaboration with the Chief Directorate Community Service at the UFS on the farms Slangfontein, Dwarsrivier and Pypersfontein in the Philippolis district.

According to Mrs Heideman, who is the co-coordinator of the project, the aim of this project was to equip farm workers with knowledge and skills regarding HIV/AIDS so that they can take control of their lives and make quality decisions.

“A major advantage of working with farm workers is that the whole family is included in the session and this ensures that all generations get the same message”, she said.

At the end the feedback from the farm workers about the programme was positive. “Many said they had tested for HIV and will continue to do so to ensure that they would be around to see their children grow up”, said Mrs Heideman.

Copies of the DVD can be obtained from Estelle Heideman (0828211230) or Tarryn Nell (0832573843).

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za  
26 September 2008


 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept